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Volume 58, Number 3 Abstracts 849for CMI were 1.8/2.0/2.1% for OR, 7.1/9.5/9.8% for repeat PTA/S, and
6.6/7.8/8.4% for readmission without repair. During the index admission,
mortality after OR was higher than PTA/S for both AMI (35% vs 19%; P <
.001) and CMI (10% vs 2%; P < .001). Three deaths occurred during
a revisit: two after OR, one after PTA/S; all three for CMI. When revisits
were excluded, the rise in PTA/S procedures persisted for CMI (Fig).
Conclusions: Revisits after mesenteric revascularization are most
frequent after PTA/S for CMI. After excluding reinterventions, numbers
of PTA/S are still increasing, so the rise in PTA/S is attributable mostly
to treatment of new patients. PTA/S is increasingly being performed in
the outpatient setting.Fig 1. Remodeling of the stented aortic segment over time. SFL, Stented
false lumen; SMAX, maximum stented diameter; STL, stented true
lumen.Evolving Treatment Patterns for Type B Aortic Dissection: Sicker
Patients, Better Results
Douglas W. Jones,1 Philip P. Goodney,2 Brian W. Nolan,2 Benjamin S.
Brooke,2 Richard J. Powell,2 David H. Stone2. 1New York Presbyterian
Hospital/Weill-Cornell Medical Center, New York, NY; 2Dartmouth-
Hitchcock Medical Center, Lebanon, NH
Objectives: The application of thoracic endovascular aortic repair
(TEVAR) has changed treatment paradigms for thoracic aortic disease.
We sought to better deﬁne speciﬁc treatment patterns and outcomes for
Type B aortic dissection treated with TEVAR or open surgical repair
(OSR).
Methods: Medicare patients undergoing thoracic aortic dissection
repair (2000-2010) were identiﬁed using a validated International Classiﬁ-
cation of Diseases-Ninth Revision diagnostic and procedural code-based
algorithm. Trends in utilization were analyzed by procedure type (OSR vs
TEVAR), and secular patterns in patient characteristics and outcomes
were examined.
Results: Total thoracic aortic dissection repairs increased by 21%
between 2000 and 2010 (2.5 to 3 per 100,000 Medicare patients; P <
.001; Fig). A concomitant increase in TEVAR was seen during the same
interval (0.03 to 0.8 per 100,000; P < .001). By 2010, TEVAR comprised
27% of all repairs. TEVAR patients had higher rates of comorbid congestive
heart failure (P < .001), chronic obstructive pulmonary disease (P < .001),
diabetes (P < .001), and chronic renal failure (P < .001) when compared
with OSR. For all repairs, patient comorbidity burden increased over time
(proportion of patients with Charlson comorbidity score greater than 2: 13%
in 2000, 18% in 2010; P < .001). During this same interval, in-hospital
mortality rates declined from 47% to 23% (P < .001). While in-hospital
mortality rates and 3-year survival were similar between patients selected for
TEVAR and OSR, women had slightly lower 3-year survival following
TEVAR (60% women vs 63% men; P ¼ .05).
Conclusions: Surgical treatment of type B aortic dissection has
increased over time, reﬂecting an increase in the utilization of TEVAR,
and is currently performed in sicker patients with better outcomes. While
perioperative mortality has improved for both OSR and TEVAR, slightly
worse survival for women with TEVAR requires further investigation.Fig.Late Aortic Remodeling Persists in the Stented Segment After
Endovascular Repair of Acute Complicated Type B Aortic Dissection
Mark F. Conrad, Christopher J. Kwolek, Shankha Mukhopadhyay, Virendra
I. Patel, Richard P. Cambria. Massachusetts General Hospital, Boston, MassObjectives: Thoracic endovascular aortic repair (TEVAR) for acute
complicated type B dissection (cTBD) promotes early positive aortic remod-
eling. However, little is known about the long-term effect of TEVAR on the
dissected aorta, which is the goal of this study.
Methods: Between August 2005 and August 2009, 31 patients with
cTBD were treated with TEVAR and had long-term (>1 year) follow-up
imaging. CTA obtained at 1 month (1M), 1 year (1Y), and long-term
(LT; average 42 months) were compared with baseline (BL) scans. The
largest diameters of the stented thoracic aorta (SMAX), stented true lumen
(STL), and stented false lumen (SFL) were recorded at each time point, as
were the values in the unstented distal thoracic aorta and the abdominal
aorta. Changes over time were evaluated using a mixed effect analysis of
variance model of repeated measures.
Results: Demographics: age 56 years; 74% male. Indications for
TEVAR: 61% malperfusion, 32% refractory hypertension, 45% impending
rupture, 32% persistent pain; 58% had >one indication. The average length
of aorta covered was 19 cm. Aortic remodeling along the stented segment is
summarized in Fig 1. The SMAX remained stable (P ¼ not signiﬁcant), STL
increased (P < .001), and SFL decreased (P < .001) over time; 84% had
complete false lumen (FL) obliteration. For the uncovered segment, the
maximum diameter increased (P ¼ .014), as did TL (P < .001) and the
visceral segment (P < .001). The FL was stable (P ¼ not signiﬁcant). Theaverage growth of the visceral segment was 31% in patients with a patent FL
vs 3% in those without (P ¼ .004). One patient had aneurysmal degener-
ation of the false lumen and required an additional endograft at 2 years.
Conclusions: TEVAR of cTBD promotes long-term remodeling
across the stented segment with FL obliteration in 84% of patients.
However, FL obliteration beyond the stented segment appears necessary
to prevent late aneurysmal degeneration.Results of Transcaval Embolization for Sac Expansion from Type II
Endoleaks After EVAR
Kristina Giles,1 Mark F. Fillinger,1 Randall R. De Martino,1 Andrew W.
Hoel,2 Richard J. Powell,1 Daniel B. Walsh1. 1Dartmouth Hitchcock
Medical Center, Lebanon, NH; 2Northwestern University Feinberg
School of Medicine, Chicago, Ill
Objectives: The increase of endovascular aortic repair (EVAR) has
been accompanied by a consequent increase in Type II endoleaks. This
study reports our experience with transcaval coil embolization (TCCE),
a novel strategy to treat this complication.
Methods: We reviewed 24 consecutive patients undergoing TCCE
from 2010 to 2013. Demographics, operative details, and outcomes were
assessed.
Results: Since 2006, over 450 EVARs have been performed at our
institution with 24 TCCE performed in 22 patients for sac expansion
from Type II endoleaks. Patients were male (87%) former or current
smokers (87%) with an average age of 78 (67.2) years. TCCE was per-
formed a mean of 4.2 (64) years after initial EVAR (21% for rupture).
Endoleaks resulted in a mean sac growth of 1.2 (60.9) cm diameter and
38% 6 35% volume. Forty-two percent had failed prior procedures (ﬁve
translumbar, two transcaval, two aortic cuff, two internal iliac branch embo-
lization, and one fenestrated branched endograft). Two patients had ulti-
mate sac access between the endograft iliac limb and arterial wall after
transcaval puncture failed with an overall 87% technical success (79% for
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with 29 (622) mL contrast used and mean 9.7 coils per case. Additional
adjuncts included thrombin injection (21%), intravascular ultrasound
(13%), sac pressure measurements (29%), and on table integrated computed
tomography (17%). Median length of stay was 1 day (range, 0-5 days).
Reintervention was required in four cases (two repeat TCCE, one open
sac plication, one branched fenestrated endograft for proximal degenera-
tion). On last follow-up, 77% experienced no further leak and stable sac
diameters, 9% had continued endoleak with sac expansion, and 14% are
awaiting follow-up imaging. There have been no ruptures during follow-up.
Conclusions: TCCE is a safe technique which provides another
option for treatment of aneurysm enlargement due to Type II endoleaks.Outcomes Reported by the Vascular Quality Initiative and the
National Surgical Quality Improvement Program Are not Comparable
Francesco Aiello, Bing Shue, Nisha Kini, William Robinson III, Louis
Messina, Andres Schanzer. University of Massachusetts Medical School,
Worcester, Mass
Objectives: The Vascular Quality Initiative (VQI) and the National
Surgical Quality Improvement Program (NSQIP) are databases of vascular
surgery outcomes. VQI uses self-reporting to capture all vascular procedures
during the inpatient period. NSQIP employs nurse abstractors to capture
a sample of procedures and covers 30-day events. We hypothesize that
patients undergoing lower extremity bypass (LEB) exhibit high concor-
dance for preoperative variables and low concordance for postoperative
variable.
Methods: All LEB patients at University of Massachusetts in both
VQI and NSQIP databases were reviewed (2008-2012). Concordance
between shared variables was analyzed by Kappa Coefﬁcient. Postoperative
variables were compared during equivalent inpatient stay. Events between
discharge and 30 days were tabulated.
Results: For 241 patients in both VQI and NSQIP, concordance of
preoperative variables was high, except for congestive heart failure (k ¼
0.14). Concordance for inpatient postoperative variables was high for
mortality (k ¼ 1.0) and myocardial infarction (k ¼ 0.75) but low for wound
infection (k ¼ 0.01), pneumonia (k ¼ 0.004), change in renal function
(k ¼ 0.007), and return to operating room (k ¼ 0.45). A majority of post-
operative events (67%) occurred between discharge and 30 days, with
a signiﬁcantly higher incidence of wound infections in the outpatient setting
(9.1% vs 90.9%; P ¼ .0001).Fig.
Table. Projected long-term costs and health beneﬁts of the strategies examined
Management strategy
Limb salvage
at 5 years, %
Median 10-year total costs,
2011 USD
Local wound care 14.1 117,148










Primary major amputation 0 151,041Conclusions: VQI and NSQIP demonstrate high concordance for
most preoperative variables but low concordance for most postoperative
variables, even at identical collection periods. This discordance is a result
of differences in data collection methods and variable deﬁnitions. Outcomes
between the two databases should not be compared between institutions.The Correlation Between the Psoas Muscle/Vertebral Body Ratio and
Severity of Peripheral Artery Disease
Sarah Swanson, Robert Patterson. Brown University, Providence, RI
Objectives: The measurement of psoas muscle area is a new and
potentially useful tool for assessing the frailty of patients in the context
of various disease states ranging from cancer to abdominal aortic aneurysms
(AAA). Considering the similarity of risk factors for frailty and atheroscle-
rosis, we sought to investigate whether patients with peripheral artery
disease (PAD) have smaller psoas muscle areas in general. Further, we
investigated whether PAD symptom severity correlates with psoas muscle
size.
Methods: A chart review was conducted on 146 patients with PAD.
Of these patients, 85 (58%) had a computed tomography (CT) scan within
the last 5 years and were included in the study. Fifty-ﬁve patients with AAA
and no occlusive disease were included as controls. Cross-sectional areas of
the psoas muscles and L4 vertebral body were collected at the mid-L4 level
for all patients. Total psoas muscle area (TPA) was calculated and divided by
L4 area to correct for body habitus. Ankle-brachial indices, claudication, rest
pain, ulceration, tissue loss, and Rutherford classiﬁcation were collected as
measures of PAD symptom severity. Logistic and multiple regressions
were run to assess the difference in TPA/L4 ratio between patients with
PAD and AAA, and within PAD patients, respectively.
Results: Lower TPA/L4 ratio controlled for gender and age is a signif-
icant predictor of having PAD vs AAA (P < .05). However, among patients
with PAD, TPA/L4 ratio does not correlate with severity of symptoms.
Conclusions: Using psoas muscle area as a measure of frailty, patients
with PAD may be generally frail as a group. However, the severity of each
patient’s PAD symptoms does not appear to correlate with the patient’s
degree of frailty. Prospective studies with larger populations are needed to
clarify whether the psoas muscle area has any prognostic value in PAD.The Cost-effectiveness of Managing Non-healing Foot Wounds in
Patients with Critical Limb Ischemia and End-Stage Renal Disease
Neal R. Barshes,1 Panos Kougias,1 C. Keith Ozaki,2 Philip P. Goodney,3
Michael Belkin2. 1Baylor College of Medicine, Houston, Tex; 2Brigham
and Women’s Hospital, Boston, Mass; 3Dartmouth-Hitchcock Medical
Center, Lebanon, NH
Objectives: Limb revascularization in patients with end-stage renal
disease (ESRD) has been criticized because of the low rates of wound heal-
ing, limb preservation, and survival that characterize this patient population.
We undertook a formal cost-effectiveness analysis to evaluate the role of
revascularization in the ESRD population.
Methods: A probabilistic Markov model was used to simulate the
clinical events and long-term outcomes following six different strategies
for managing non-healing foot wounds in patients with critical limb
ischemia and ESRD. All scenarios considered all-cause mortality and major
amputation for failure of limb salvage. The estimates of parameters used in
the model, including costs, functional outcomes, and clinical events, were
derived from primary data or published literature. One-year wound healing
probabilities of 20% and 50% with and without revascularization, respec-
tively, were assumed; these were varied from 10% to 90% in deterministic




Cost per year of ambulation,
2011 USD
0.95 1.71 Reference
1.81 1.87 50,943
1.75 1.82 Dominated
1.63 1.73 Dominated
1.63 1.73 Dominated
0 1.20 Dominated
